News

TB R&D Weekly Update: Redefining Tuberculosis Immunopathology

Elkington PT, D’Armiento JM, Friedland JS. Tuberculosis immunopathology: the neglected role of extracellular matrix destruction. Sci Transl Med. 2011 Feb 23;3(71):71ps6.

In today’s article, Elkington, et al., would like to change how researchers view and define immunopathology in tuberculosis. The immune response to tuberculosis (TB) and resulting tissue damage has been recognized as a cause of mortality in TB patients but the terms such “caseous necrosis” used to capture what occurs during disease maybe inadequate.

In the past, the role of proteases and other enzymes in the breakdown of lung tissue and the formation of cavities was recognized by pioneers such as Lure and Dannenberg. Recent models of cavity formation have seem to ignore this role and focused more on immune cell and cytokine responses. Caseous necrosis is viewed as one process.

The authors suggest that the term “caseous necrosis” should actually be split into three processes: 1) The toxicity of Mycobacterium tuberculosis infection on macrophages causes cell necrosis 2) The response by activated T cells is a driver of the pathology 3) Protease activity works to break down the extracellular matrix of the lung.

This changed model identifies a target for antituberculous drugs with already identified compounds such as Doxycycline which is currently used for periodontal disease and a potent collangenase inhibitor, Ro32-3555 which has completed Phase III testing for arthritis. Targeting the enzymes responsible for the destruction of the extracellular matrix of the lung may help reduce the morbidity and mortality caused by TB.

Additional TB R&D News:

New antibody therapy to tackle tuberculosis

FIND and Global BioDiagnostics Enter into Agreement to Develop POC Test for Tuberculosis

Whole-genome sequencing and social-network analysis of a tuberculosis outbreak

ISU researchers find clue to stopping tuberculosis

Elkington PT, D’Armiento JM, Friedland JS. Tuberculosis immunopathology: the neglected role of extracellular matrix destruction. Sci Transl Med. 2011 Feb 23;3(71):71ps6.

Elkington PT, D’Armiento JM, Friedland JS. Tuberculosis immunopathology: the neglected role of extracellular matrix destruction. Sci Transl Med. 2011 Feb 23;3(71):71ps6.

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...